Publication - Advice and guidance

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows administration during or in anticipation of COVID-19 pandemic.

Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech vaccine: national protocol v2.4
Annex C: Clinical Supervision sheet

Annex C: Clinical Supervision sheet

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTechVaccine Protocol

Valid from: Expiry:

This sheet must record the name of the clinical supervisor taking responsibility and all of the people working under different activity stages of the protocol.

Activity stages of the vaccination pathway under this protocol:

Stage 1 a. Assessment of the individual presenting for vaccination
b. Provide information and obtain informed consent
c. Provide advice to the individual
Registered Healthcare Professionals Only
Stage 2
  • Vaccine Preparation
Registered Healthcare Professionals, non-registered professionals or non-registered Armed Forces staff
Stage 3
  • Vaccine Administration
Registered Healthcare Professionals, non-registered professionals or non-registered Armed Forces staff
Stage 4
  • Record Keeping
Registered Healthcare Professionals, non-registered professionals or non-registered Armed Forces staff

The clinical supervisor has ultimate responsibility for safe care being provided under the terms of the protocol. Persons working under the protocol may be supported by additional registered healthcare professionals, but the clinical supervisor retains responsibility.

Before signing this Protocol, check that the document has had the necessary authorisations. Without these, this Protocol is not lawfully valid.

Clinical Supervisor

Practitioner(s) and Activity Stages

Note to Clinical Supervisor

Score through unused rows in the list of practitioners to prevent practitioner additions post managerial authorisation.

This authorisation sheet should be retained to serve as a record of clinical supervision arrangements for those working under this Protocol.


Contact

Email: vaccineoperationaloversight@gov.scot